載入...
Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade
Immune checkpoint inhibitors have demonstrated broad single-agent antitumor activity and a favorable safety profile that render them attractive agents to combine with other systemic anticancer therapies. Pancreatic cancer has been fairly resistant to monotherapy blockade of programmed cell death pro...
Na minha lista:
| 發表在: | Clin Transl Med |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Berlin Heidelberg
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6174117/ https://ncbi.nlm.nih.gov/pubmed/30294755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-018-0210-9 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|